Rothwell Investment Advisors, LLC’s West Pharmaceutical WST Stock Holding History

Rothwell Investment Advisors, LLC’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$21.6K	Buy	+58	New	+$20.5K	0.01%	605

Other funds holding WST

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return

Rothwell Investment Advisors, LLC's WST Position: Q3 2026 in Review

Rothwell Investment Advisors, LLC opened a new position in West Pharmaceutical (WST) in Q3 2026: 58 shares worth $21.6K. The stake represents 0.01% of the portfolio and ranks #605 among its holdings.

430 funds tracked by Wall St. Rank hold WST as of Q3 2026.

Rothwell Investment Advisors, LLC held 58 shares of West Pharmaceutical worth $21.6K as of Q3 2026.
West Pharmaceutical was a new Rothwell Investment Advisors, LLC position in Q3 2026.
West Pharmaceutical made up 0.01% of Rothwell Investment Advisors, LLC's portfolio in Q3 2026, its #605 holding.
430 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on Rothwell Investment Advisors, LLC's 13F filing for Q3 2026, filed 6 Nov 2026.